This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $2,066.94 firm fixed price delivery order has a completion date of November 1, 2024 and is not set aside. Dakota Drug, Inc. holds a large single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through December 31, 2025.
Generated 1/30/25, 9:18 AM